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Vav1 is physiologically expressed exclusively in haematopoietic cells, where it is a 
critical signal transducer in immune response. In addition to acting as a GEF involved 
in cytoskeleton rearrangement, Vav1 is an adapter molecule facilitating the interaction 
between other signaling proteins. Studies performed using knockout mice provided 
important insights into the function of Vav1 in both development and function of he-
matopoietic cells, including macrophages, in which it regulates adhesion, motility and 
migration speed.
In addition to modulate the acquisition of a mature phenotype by normal hemat-
opoietic cells, Vav1 is a crucial molecule in the agonist-induced completion of the dif-
ferentiation program of tumoral myeloid precursors. In particular, we have found that 
the over-expression of Vav1 promotes the overcoming of the differentiation blockade 
and enhances the ATRA-induced maturation of cells derived from acute promyelocytic 
leukemia (APL). We have also demonstrated that Vav1 modulates the expression level 
of the protein tool by means of which ATRA executes the differentiation program of tu-
moral myeloid precursors, possibly as part of transcriptional complexes. 
Despite the multiple function played by Vav1 during the maturation to neutrophils 
of tumoral promyelocytes, none is known about a possible role for this protein in the 
differentiation of leukemic precursors to monocytes/macrophages. To address this is-
sue, tumoral promyelocytes in which Vav1 was negatively modulated were induced to 
differentiate into monocytes/macrophages with PMA and monitored for their matu-
ration level. Our data indicate that Vav1 is crucial for phenotypical differentiation of 
APL-derived cells to monocytes/macrophages, in terms of CD11b expression, adhesion 
capability and cell morphology. In addition, we have found that Vav1 and actin may 
cooperate in modulating nuclear morphology of PMA-treated adherent cells.
The obtained results allowed to establish that, in the same tumoral myeloid precur-
sors, Vav1 may be recruited by different agonists as part of lineage-specific transduction 
machineries, highlighting the key role for this protein in the completion of the differen-
tiation program of leukemic promyelocytes and suggesting Vav1 as a common target for 
the differentiation therapy of different subtypes of myeloid leukemias along the diverse 
hematopoietic lineages.
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